D Policy

CHICAGO—A campaign to increase federal support for research and industrial applications of new technology began last month with a series of conferences held throughout the country. The conferences were designed both to garner support and thinking on new R&D initiatives and to provide regional views on global competitiveness and the declining technological status of the United States. Sponsored by the businessoriented Conference Board and the Council on Research and Technology (CORETECH

Written byGail Mcbride
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

CHICAGO—A campaign to increase federal support for research and industrial applications of new technology began last month with a series of conferences held throughout the country.

The conferences were designed both to garner support and thinking on new R&D initiatives and to provide regional views on global competitiveness and the declining technological status of the United States. Sponsored by the businessoriented Conference Board and the Council on Research and Technology (CORETECH), the four day-long meetings featured calls to action by prominent figures in science and industry as well as workshops on federal programs to encourage cooperative research efforts.

“There’s a consensus on such issues as the need to safeguard our basic scientific and technical resources,” explained Stephanie Becker of CORETECH, a Washington-based lobbying coalition of research universities, high-tech industries and trade and professional organizations formed last February. “But there’s a lot of new ideas, too, such as innovative ways to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies